Kura Oncology, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
KURA on Nasdaq
Location
12730 High Bluff Drive, Suite 400, San Diego, CA

Insiders trading volume in the past year

Kura Oncology, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Troy E. Wilson President and CEO, Director $11.7M Jan 2, 2025
Thomas Malley Director $1.6M Jun 5, 2024
Teresa Bair Chief Legal Officer $850K -$115K -11.9% Jan 28, 2025
Stephen Dale Chief Medical Officer $837K Jan 29, 2024
Thomas Doyle SVP, Finance & Accounting $698K -$39K -5.29% Jan 28, 2025
Mollie Leoni Chief Medical Officer $695K -$39.1K -5.32% Jan 28, 2025
Brian Powl Chief Commercial Officer $470K -$12.5K -2.58% Jan 28, 2025
Marc Grasso Cfo, Cbo $252K Jan 26, 2022
Kirsten Flowers CCO & Chief Strategy Officer $237K Jan 27, 2023
Kathleen Ford Chief Operating Officer $168K -$22.7K -11.9% Jan 28, 2025
Francis Burrows Chief Scientific Officer $163K -$17.1K -9.47% Jan 28, 2025
Faheem Hasnain Director Jun 5, 2024
Steven H. Stein Director Jun 21, 2022
Mary T. Szela Director Jun 5, 2024
Diane L. Parks Director Jun 5, 2024
Helen Louise Collins Director Jun 5, 2024
Carol Schafer Director Jun 5, 2024
Michael Vasconcelles Director Sep 13, 2024
Robert E. Hoffman Director Jun 22, 2021

Recent Insider Transactions by Companies or Individuals for Kura Oncology, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.